Projects funded by the NCN

Simultaneous stimulation of muscarinic M4 receptor and selected receptors involved in the regulation of glutamate releas...

Call: OPUS 9 , Panel: NZ7

Principal investigator: dr hab. Joanna Wierońska

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

Synthesis and pharmacological evaluation of novel benzizoxazolepropylpyrolidine derivatives as multifunctional ligands w...

Call: SONATA 8 , Panel: NZ7

Principal investigator: dr Monika Marcinkowska

Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

Antidepressats as substances that increase the activity of risperidone, an atypical antipsychotic drug in animal models

Call: PRELUDIUM 5 , Panel: NZ7

Principal investigator: Katarzyna Kamińska

Instytut Farmakologii PAN

The effect of imipramine and risperidone on regulation of the chronic mild stress-induced anhedonia and memory impairmen...

Call: OPUS 5 , Panel: NZ7

Principal investigator: dr hab. Mariusz Papp

Instytut Farmakologii PAN

Interaction of dopamine receptors with G proteins – structural and kinetic aspects

Call: OPUS 1 , Panel: NZ1

Principal investigator: dr Agnieszka Polit

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

Synthesis and pharmacological properties of mono- di- and triheterocyclic azole derivatives as a hybrid receptor and PDE...

Call: OPUS 4 , Panel: NZ7

Principal investigator: prof. Maciej Pawłowski

Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

The group III metabotropic glutamate receptors as a target for future antypsychotic drugs

Call: MAESTRO 3 , Panel: NZ7

Principal investigator: prof. Andrzej Pilc

Instytut Farmakologii PAN

Molecular profiling of novel antipsychotic drug candidates

Call: OPUS 20 , Panel: NZ7

Principal investigator: dr hab. Jan Rodriguez Parkitna

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

Novel multi-target ligands of aminergic GPCRs as pharmacological tools to study the pathomechanism of schzophrenia

Call: OPUS 14 , Panel: NZ7

Principal investigator: dr hab. Agnieszka Kaczor

Uniwersytet Medyczny w Lublinie, Wydział Farmaceutyczny

Atypical antipsychotic drugs effects on pro-and antioxidative processes, and apoptosis - a study in blood cells, plasma,...

Call: OPUS 1 , Panel: NZ4

Principal investigator: dr hab. Anna Dietrich-Muszalska

Uniwersytet Medyczny w Łodzi, Wydział Lekarski

Comparative effects of 1-methyl-1,2,3,4-tetrahydroisoquinoline (1MeTIQ) and olanzapine on the cognitive dysfunction meas...

Call: OPUS 13 , Panel: NZ7

Principal investigator: dr hab. Agnieszka Wąsik

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

Characterization of clozapine and risperidone mechnism of action at the cell nucleus level

Call: OPUS 13 , Panel: NZ4

Principal investigator: dr hab. Sylwia Kędracka-Krok

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

The role of the neuron-microglia CX3CL1-CX3CR1 and CD200-CD200R protein systems in molecular mechanisms of antipsychotic...

Call: OPUS 10 , Panel: NZ7

Principal investigator: prof. Agnieszka Basta-Kaim

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

5-HT6 receptor ligands as addition to antipsychotic therapy in schizophrenia - an impact on body weight, metabolic param...

Call: OPUS 10 , Panel: NZ7

Principal investigator: prof. Anna Wesołowska

Uniwersytet Jagielloński Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny